Fat embolism syndrome is a rare, potentially fatal systemic condition caused by embolization of fat droplets into the pulmonary and systemic circulation, classically presenting with the triad of respiratory distress, neurologic dysfunction, and petechial rash within 24–72 hours of long bone fractures or orthopedic procedures. [1-3] Incidence ranges from 0.5–11% in patients with long bone fractures, though subclinical fat embolism occurs in the majority of fracture patients. [2][4] Mortality in severe cases ranges from approximately 5–18%. [5-6]
1. History
- Timing: Symptom onset typically 24–72 hours after the inciting event; post-liposuction cases may present as early as 1.8 hours [2][7]
- Inciting event: Long bone fractures (especially femur), pelvic fractures, orthopedic procedures (intramedullary nailing, arthroplasty, cemented prostheses), liposuction, or sickle cell crisis with bone marrow necrosis [5][7-8]
- Symptom progression: Often begins with tachypnea and hypoxemia → followed by confusion, agitation, or obtundation → then petechial rash (may appear last or not at all)
- Key HPI questions:
- What was the mechanism and timing of injury/surgery?
- When did respiratory symptoms begin relative to the injury?
- Any change in mental status, confusion, or drowsiness?
- Any rash noted on the chest, axillae, or conjunctivae?
- Important negatives: Absence of head trauma (to distinguish neurologic changes from TBI), no history of DVT/PE risk factors, no chest trauma explaining hypoxia
2. Alarm Features
- Acute hypoxemia (PaO₂ < 60 mmHg) within 24–72 hours of fracture/surgery [9]
- Sudden altered mental status or coma — may indicate cerebral fat embolism [3][10]
- Rapidly progressive respiratory failure requiring intubation [11]
- Hemodynamic instability with right ventricular dilatation/failure on echocardiography [12-13]
- Seizures or focal neurologic deficits [2][10]
- Petechial rash in a non-dependent distribution (upper chest, axillae, conjunctivae) — highly suggestive but present in only ~50–60% of cases [2][7]
- Retinal fat emboli on fundoscopy (Purtscher-like retinopathy) [8][14]
3. Medications
- No specific pharmacologic treatment exists; management is primarily supportive [1-2]
- Corticosteroids: Methylprednisolone has been used both prophylactically and therapeutically, though efficacy remains debated. Some evidence suggests reduced mortality and improved hemodynamics. Typical regimens include methylprednisolone 1.5 mg/kg IV q8h for prophylaxis or higher pulse doses (250 mg–1 g) for treatment [2][12][15]
- Heparin: Historically used but benefit is unclear and not routinely recommended [16]
- High-intensity statins: Empirically used in some centers for cerebral FES, with a trend toward decreased microembolic signals on transcranial Doppler [14]
- Avoid: Overaggressive fluid resuscitation (risk of worsening pulmonary edema); no role for thrombolytics
4. Diet
- Not a primary consideration in acute FES management
- NPO if intubation is anticipated or the patient has altered mental status
- Early enteral nutrition should be initiated per standard ICU protocols once hemodynamically stable
- Adequate hydration is important to maintain intravascular volume and prevent hypovolemia, which may worsen fat embolization [11]
5. Review of Systems
- Pulmonary: Dyspnea, tachypnea, pleuritic chest pain, cough
- Neurologic: Confusion, agitation, drowsiness, seizures, focal deficits, coma [3][10]
- Dermatologic: Petechial rash (upper body, axillae, conjunctivae) [2]
- Ophthalmologic: Visual changes (retinal fat emboli) [8][14]
- Hematologic: Signs of anemia, easy bruising (thrombocytopenia)
- Constitutional: Fever (often >38.5°C), tachycardia [9][15]
6. Collateral History and Family History
- Collateral: Mechanism and timing of injury, surgical details (reaming, cementation), pre-injury functional status, witnessed seizures or mental status changes
- Family history: Generally not contributory unless evaluating for sickle cell disease, which is a non-traumatic cause of FES via bone marrow necrosis [5][17]
- Social context: Liposuction or cosmetic surgery history (increasingly recognized cause) [7][18]
7. Risk Factors
- Long bone fractures (especially femur) — strongest risk factor [1][6]
- Multiple fractures and higher Injury Severity Score [6]
- Open fractures of extremities [6]
- Pelvic fractures [8]
- Delayed fracture fixation (>24 hours) — associated with a 2.2-fold increased risk of FES [6]
- Intramedullary nailing/reaming and cemented arthroplasty [13][19]
- Liposuction (especially large-volume) [7]
- Sickle cell disease with vaso-occlusive crisis and bone marrow necrosis [5][17]
- Young age and male sex (higher fracture incidence) [1]
- Patent foramen ovale (PFO) — allows paradoxical embolism to the systemic/cerebral circulation, worsening neurologic manifestations [13][20]
8. Differential Diagnosis
- Pulmonary thromboembolism (PE): CTA shows filling defects; FES typically CTA-negative [12]
- ARDS from other causes: Sepsis, aspiration, transfusion-related; FES-related ARDS has characteristic timing post-fracture
- Traumatic brain injury: Must be excluded with imaging; FES can mimic TBI in polytrauma [3]
- Acute cerebral infarction: FES can be misdiagnosed as stroke; MRI starfield pattern distinguishes [20-21]
- Sepsis/pneumonia: Fever and bilateral infiltrates overlap; FES has petechiae and characteristic timing
- Thrombotic thrombocytopenic purpura (TTP): Thrombocytopenia + neurologic changes, but different clinical context
- Air embolism: Especially post-procedural; different mechanism and imaging findings [2]
- Acute chest syndrome (in sickle cell disease): Overlaps significantly with FES in SCD patients [5][17]
9. Past Medical History
- Sickle cell disease — non-traumatic FES risk [5][17]
- Prior long bone fractures or orthopedic procedures
- Known PFO or intracardiac shunt — increases risk of paradoxical/cerebral embolism [13][20]
- History of DVT/PE
- Chronic lung disease (lower reserve for respiratory compromise)
- Prior liposuction or cosmetic procedures [7]
10. Physical Exam
- Vital signs: Tachypnea, tachycardia, fever (>38.5°C), hypoxemia (SpO₂ often <90% on room air), hypotension in severe cases [9][11]
- Pulmonary: Bilateral crackles, increased work of breathing
- Neurologic: Altered mental status ranging from confusion to coma; may have focal deficits or seizures [3][10]
- Skin: Petechial rash — classically on the upper chest, axillae, neck, and conjunctivae; non-palpable, transient (may resolve within 24–48 hours) [2][9]
- Eyes: Dilated fundoscopy may reveal retinal fat emboli (cotton-wool spots, hemorrhages) — present in up to 95% of cerebral FES cases [14]
- Cardiovascular: Signs of right heart strain (elevated JVP, RV heave) in severe cases; echocardiography may show RV dilatation [12][22]
11. Lab Studies
- ABG: Hypoxemia (PaO₂ <60 mmHg) — often the earliest finding; monitor serially [9]
- CBC: Anemia (unexplained drop in hemoglobin), thrombocytopenia [5][7-8]
- Coagulation: Elevated D-dimer, elevated fibrin split products [7][9]
- Inflammatory markers: Elevated CRP, elevated ESR [5]
- LDH: Often elevated (reflects tissue ischemia) [5]
- Lipase: May be elevated but nonspecific
- Serum calcium: May be decreased (calcium binds free fatty acids)
- Urinalysis: Fat globules in urine (low sensitivity)
- Reticulocyte count: Reticulocytopenia in SCD-related FES [5]
Note: No single lab test is diagnostic. The Gurd and Wilson criteria remain the most widely used clinical diagnostic framework, requiring at least one major criterion (petechial rash, respiratory insufficiency, cerebral involvement) plus at least four minor criteria (tachycardia, fever, retinal changes, fat in urine, unexplained drop in Hgb/Hct, elevated ESR, fat macroglobulinemia). [4][10][13]
12. Imaging
- Chest X-ray: May be normal early; later shows bilateral diffuse infiltrates ("snowstorm" pattern) similar to ARDS [9]
- Chest CT: Diffuse bilateral ground-glass opacities, interlobular septal thickening, ill-defined centrilobular nodules, patchy consolidation — most common radiographic finding (present in ~90% of cases) [7][16][23]
- CT Pulmonary Angiography: Typically negative for filling defects — important to rule out PE [12]
- Brain MRI (DWI): "Starfield pattern" — scattered punctate high-signal lesions on diffusion-weighted imaging representing cytotoxic edema from microemboli; highly characteristic and the most sensitive neuroimaging finding [21-22][24]
- Brain CT: May show multiple cerebral infarctions but is less sensitive than MRI [7]
- Echocardiography: May reveal RV dilatation, elevated pulmonary pressures, or echogenic material in cardiac chambers; evaluate for PFO with bubble study [12-13][20]
13. Special Tests
- Gurd and Wilson Criteria: Most widely used diagnostic scoring system (major + minor criteria) [4][10]
- Schonfeld Fat Embolism Index: Quantitative scoring system; score ≥5 suggests FES [17]
- Bronchoalveolar lavage (BAL): Oil Red O staining of alveolar macrophages — >30% of cells containing fat droplets is suggestive of FES; however, sensitivity and specificity are debated (fat droplets can be found in trauma patients without FES) [25-28]
- Transcranial Doppler (TCD): Detects microembolic signals (HITS) in cerebral circulation; presence associated with PFO and cerebral involvement [14]
- TCD bubble test: Can detect right-to-left shunting (PFO) [20]
- Dilated fundoscopy: Retinal fat emboli visible in majority of cerebral FES cases [14]
14. ECG
- ECG findings are nonspecific but may include:
- Sinus tachycardia (most common)
- Right heart strain pattern: Right axis deviation, S1Q3T3, RBBB, T-wave inversions in anterior/inferior leads
- ST-segment changes or nonspecific ST-T wave abnormalities
- Atrial fibrillation or other tachyarrhythmias in severe cases
- ECG is primarily useful to rule out acute MI and assess for right heart strain in the setting of acute hypoxemia and hemodynamic instability [12]
15. Assessment
- FES is a clinical diagnosis supported by imaging and laboratory findings; no single gold-standard test exists [1][10]
- The classic triad (respiratory distress + neurologic changes + petechiae) is present in only a minority of cases; incomplete forms are common [13]
- Severity spectrum: Subclinical → mild (isolated hypoxemia) → fulminant (multiorgan failure, coma, cardiovascular collapse) [3][13]
- Typical presentation: Young trauma patient with femur fracture who develops unexplained hypoxemia and confusion 24–48 hours post-injury [1][9]
- Atypical presentations: Post-liposuction (rapid onset), sickle cell crisis (non-traumatic), minor orthopedic procedures, undisplaced fractures [5][7-8][29]
- Complications: ARDS, cerebral infarction, right heart failure, DIC, multiorgan failure, death [5][13]
- Prognosis: Most cases resolve with supportive care; even comatose patients may recover favorably [3]
16. Treatment Plan
Initial Stabilization
- Airway/Breathing: Supplemental O₂ to maintain SpO₂ >92%; early intubation and mechanical ventilation for severe respiratory failure; use lung-protective ventilation (low tidal volume 6 mL/kg IBW) as for ARDS [2][11]
- Circulation: IV fluid resuscitation to maintain euvolemia and hemodynamic stability; vasopressors (norepinephrine) for refractory hypotension [2][12]
Pharmacologic
- Corticosteroids: Consider methylprednisolone (dose varies: 1.5 mg/kg q8h or pulse 250 mg–1 g IV) — may reduce inflammation and improve hemodynamics, though evidence is not definitive [2][12][15]
- VTE prophylaxis: Standard DVT prophylaxis per trauma protocols [2]
- Supportive ICU care: Stress ulcer prophylaxis, nutrition, DVT prophylaxis, glycemic control [11]
Surgical/Preventive
- Early fracture fixation (within 24 hours) reduces FES incidence by up to fivefold [2][6]
- Avoid excessive intramedullary pressure during reaming/nailing [13][19]
For SCD-related FES
17. Disposition
- ICU admission: All patients with confirmed or suspected FES, especially those with hypoxemia requiring supplemental O₂, altered mental status, hemodynamic instability, or need for mechanical ventilation [5][11]
- Observation: Patients with isolated mild hypoxemia post-fracture and high clinical suspicion should be monitored in a step-down or ICU setting with serial ABGs
- Discharge criteria: Resolution of hypoxemia, stable neurologic status, no ongoing respiratory support needed
- Specialist consultation triggers:
- Orthopedic surgery (early fracture fixation) [2][6]
- Pulmonology/Critical care (ventilator management, BAL)
- Neurology (cerebral FES, seizures)
- Hematology (SCD-related FES, exchange transfusion) [5]
- Cardiology (PFO evaluation if paradoxical embolism suspected) [20]
18. Follow Up / Return Precautions
- Follow-up timing: Outpatient follow-up within 1–2 weeks post-discharge; neurology follow-up for cerebral FES patients
- Expected recovery: Most patients recover fully with supportive care; neurologic recovery may lag behind imaging improvement — MRI lesions may persist even after consciousness is restored [24]
- Symptoms requiring immediate reassessment:
- New or worsening shortness of breath
- Confusion, drowsiness, or seizures
- New rash or petechiae
- Chest pain or hemodynamic instability
- Patient counseling:
- FES is a recognized complication of fractures/surgery; most patients recover well
- Cognitive or neurologic deficits may improve over weeks to months [3][14]
- Importance of follow-up imaging (brain MRI) to document resolution of cerebral lesions [24]
- Long-term outcomes: Among cerebral FES survivors, 57% had mild-to-moderate disability at last follow-up in one series; however, even patients presenting in coma may achieve favorable recovery [3][14]
References
1. Fat Embolism Syndrome After Trauma: What You Need to Know. — Kwon J, Coimbra R. The Journal of Trauma and Acute Care Surgery. 2024.
2. Thoracic Trauma WSES-AAST Guidelines. — Coccolini F, Cremonini C, Moore EE, et al. World Journal of Emergency Surgery : WJES. 2025.
3. Cerebral Fat Embolism: Recognition, Complications, and Prognosis. — Godoy DA, Di Napoli M, Rabinstein AA. Neurocritical Care. 2018.
4. Fat Embolism Syndrome: History, Definition, Epidemiology. — Talbot M, Schemitsch EH. Injury. 2006.
5. Clinical, Laboratory, Radiological Features, and Outcome of Acute Fat Embolism Syndrome in Sickle Cell Disease. — Salam A, Sameer R, Eiman AA, et al. Scientific Reports. 2025.
6. Risk Factors of Fat Embolism Syndrome After Trauma: A Nested Case-Control Study With the Use of a Nationwide Trauma Registry in Japan. — Kainoh T, Iriyama H, Komori A, et al. Chest. 2021.
7. Fat Embolism Syndrome Caused by Fracture or Liposuction: A Retrospective Case Series of Nine Patients. — Yan X, Wu S, Zeng W, Kong J. Annals of Medicine. 2025.
8. Fat Embolism Syndrome After Knee Arthroscopy in a Pediatric Patient. — Bassell-Hawkins J, Suresh NE, Mahoney D, et al. Chest. 2023.
9. The Fat Embolism Syndrome. — Gossling HR, Donohue TA. The Journal of the American Medical Association. 1979.
10. Pathophysiology, Clinical Manifestations, and Prognostic Insights of Cerebral Fat Embolism: A Literature Review. — Alrasheed AS, Elazrag AM, Alqahtani MS, Alabbas F. Frontiers in Neurology. 2025.
11. Therapeutic Aspects of Fat Embolism Syndrome. — Habashi NM, Andrews PL, Scalea TM. Injury. 2006.
12. Fat Embolism Syndrome Treated With Methylprednisolone. — Baba D, Yamashita Y, Fukuda Y, et al. Internal Medicine. 2025.
13. Fulminating Fat Embolism Syndrome Caused by Paradoxical Embolism through a Patent Foramen Ovale. — Pell AC, Hughes D, Keating J, et al. The New England Journal of Medicine. 1993.
14. Cerebral Fat Embolism Syndrome at a Single Trauma Center. — Singh A, Davis AP, Taylor B, et al. Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association. 2022.
15. Fat Embolism Syndrome: Never Give Up - A Case Report and Literature Review. — Liu S, Wu X, Zheng Y, et al. Medicine. 2025.
16. Fat Embolism Syndrome: State-of-the-Art Review Focused on Pulmonary Imaging Findings. — Newbigin K, Souza CA, Torres C, et al. Respiratory Medicine. 2016.
17. Integrating Fat Embolism Syndrome Scoring Indices in Sickle Cell Disease: A Practice Management Review. — Bailey K, Wesley J, Adeyinka A, Pierre L. Journal of Intensive Care Medicine. 2019.
18. Case Report: Application of Bronchoalveolar Lavage Fluid Morphology in the Diagnosis of Pulmonary Fat Embolism. — Li X, Pan Y, Qian X, Wang H, Zhou Y. Frontiers in Medicine. 2026.
19. Fat Embolism and Fat Embolism Syndrome. — Rothberg DL, Makarewich CA. The Journal of the American Academy of Orthopaedic Surgeons. 2019.
20. Fat Embolism Syndrome With Patent Foramen Ovale Combined With Brain Fat Embolism and Lung Fat Embolism: A Case Report. — Yang G, Xu J, Geng X, et al. Medicine. 2026.
21. Early Diagnosis of Cerebral Fat Embolism Syndrome by Diffusion-Weighted MRI (Starfield Pattern). — Parizel PM, Demey HE, Veeckmans G, et al. Stroke. 2001.
22. Fat Embolism Syndrome in a Patient That Sustained a Femoral Neck Fracture: A Case Report. — den Otter LAS, Vermin B, Goeijenbier M. Frontiers in Medicine. 2022.
23. Pulmonary CT Imaging Findings in Fat Embolism Syndrome: Case Series and Literature Review. — Qi M, Zhou H, Yi Q, Wang M, Tang Y. Clinical Medicine. 2023.
24. Case Report: Recovery of Consciousness Ahead of MRI Image Lesion Information in Cerebral Fat Embolism Syndrome. — Zhuang Z, Bo Y, Pan Y, Huang J. Frontiers in Medicine. 2025.
25. Role of Bronchoalveolar Lavage in the Diagnosis of Fat Embolism Syndrome. — Roger N, Xaubet A, Agustí C, et al. The European Respiratory Journal. 1995.
26. Bronchoalveolar Lavage for Rapid Diagnosis of the Fat Embolism Syndrome in Trauma Patients. — Chastre J, Fagon JY, Soler P, et al. Annals of Internal Medicine. 1990.
27. Bronchoalveolar Lavage in Trauma Patients for Diagnosis of Fat Embolism Syndrome. — Vedrinne JM, Guillaume C, Gagnieu MC, et al. Chest. 1992.
28. Contribution of Bronchoalveolar Lavage to the Diagnosis of Posttraumatic Pulmonary Fat Embolism. — Mimoz O, Edouard A, Beydon L, et al. Intensive Care Medicine. 1995.
29. Fat Embolism Syndrome in a Patient With a Right Undisplaced Femoral Neck Fracture. — Ishikawa J, Sato N, Ishigame N, et al. Age and Ageing. 2022.